A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme —- which kills thousands of Americans every year.

Source: Brain cancer vaccine proves effective, study suggests


David Cottle

UBB Owner & Administrator